ATXN2 with intermediate-length CAG/CAA repeats does not seem to be a risk factor in hereditary spastic paraplegia

Journal of the Neurological Sciences

Volumn 321, Issue 1-2, 2012, Pages 100-102

  Nielsen, Troels Tolstrup ^a,b   Svenstrup, Kirsten ^a,b   Budtz Jørgensen, Esben ^c   Eiberg, Hans ^b   Hasholt, Lis ^b   Nielsen, Jørgen E ^a,b  

^a University of Copenhagen   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

ATXN2; Hereditary spastic paraplegia; Spinocerebellar ataxia type 2

Indexed keywords

ATXN2 PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CAG REPEAT; COHORT ANALYSIS; CONTROLLED STUDY; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; MAJOR CLINICAL STUDY; ONSET AGE; PRIORITY JOURNAL; RISK FACTOR;

ANALYSIS OF VARIANCE; COHORT STUDIES; DENMARK; DNA MUTATIONAL ANALYSIS; FEMALE; HUMANS; MALE; NERVE TISSUE PROTEINS; RISK FACTORS; SPASTIC PARAPLEGIA, HEREDITARY; TRINUCLEOTIDE REPEATS;

EID: 84866007739     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2012.07.036     Document Type: Article

References (10)

1. A.K. Erichsen, J. Koht, A. Stray-Pedersen, M. Abdelnoor, and C.M. Tallaksen Prevalence of hereditary ataxia and spastic paraplegia in southeast Norway: a population-based study Brain 132 Pt 6 2009 Jun 1577 1588
2. C. Blackstone, C.J. O'Kane, and E. Reid Hereditary spastic paraplegias: membrane traffic and the motor pathway Nat Rev Neurosci 12 1 2011 Jan 31 42
3. J.K. Fink, T. Heiman-Patterson, T. Bird, F. Cambi, M.P. Dube, and D.A. Figlewicz Hereditary spastic paraplegia: advances in genetic research. Hereditary Spastic Paraplegia Working Group Neurology 46 6 1996 Jun 1507 1514
4. M. Martinez-Lage, L. Molina-Porcel, D. Falcone, L. McCluskey, V.M. Lee, and V.M. Van Deerlin TDP-43 pathology in a case of hereditary spastic paraplegia with a NIPA1/SPG6 mutation Acta Neuropathol 124 2 2012 Feb 3 285 291
5. M. Neumann, D.M. Sampathu, L.K. Kwong, A.C. Truax, M.C. Micsenyi, and T.T. Chou Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis Science 314 5796 2006 Oct 6 130 133
6. A.C. Elden, H.J. Kim, M.P. Hart, A.S. Chen-Plotkin, B.S. Johnson, and X. Fang Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS Nature 466 7310 2010 Aug 26 1069 1075
7. T. Lee, Y.R. Li, C. Ingre, M. Weber, T. Grehl, and O. Gredal Ataxin-2 intermediate-length polyglutamine expansions in European ALS patients Hum Mol Genet 20 9 2011 May 1 1697 1700
8. O.A. Ross, N.J. Rutherford, M. Baker, A.I. Soto-Ortolaza, M.M. Carrasquillo, and M. DeJesus-Hernandez Ataxin-2 repeat-length variation and neurodegeneration Hum Mol Genet 20 16 2011 Aug 15 3207 3212
9. J.E. Nielsen, P. Koefoed, K. Abell, L. Hasholt, H. Eiberg, and K. Fenger CAG repeat expansion in autosomal dominant pure spastic paraplegia linked to chromosome 2p21-p24 Hum Mol Genet 6 11 1997 Oct 1811 1816
10. Z. Yu, Y. Zhu, A.S. Chen-Plotkin, D. Clay-Falcone, L. McCluskey, and L. Elman PolyQ repeat expansions in ATXN2 associated with ALS are CAA interrupted repeats PLoS One 6 3 2011 e17951